Eating Disorders Awareness Week

Debate between Zubir Ahmed and Scott Arthur

Thursday 26th February 2026 Westminster Hall

[Dr Ahmed]

The hon. Lady makes a really valid point. She will know, as I do, that the regulation of these platforms in relation to children’s access is a live issue at the heart of Government at the moment. She is right: the current provisions are not strong enough to be adequate safeguards. We do need more proactive intervention from our technology partners. My right hon. Friend the Secretary of State for Science, Innovation and Technology takes that very seriously and is pushing very hard on it in relation to not only harm in this space, but harm in general, for children online.

Ofcom ensures that services uphold these duties, including for smaller online sites. Its small but risky services taskforce has assessed 20 services relating to this harm, over half of which have been at high risk for eating disorder content. I am happy to write to my colleagues in the Department for Science, Innovation and Technology, on the back of this debate, to learn from them what further action specific to eating disorders is coming down the pipeline, and I can relay that information to hon. Members assembled in this Chamber today.

I also share the deep concern about reports of people with eating disorders being offered end-of-life care.

[Dr Arthur]

Before we move on to end-of-life care, I welcome the great offer that the Minister has given to reach out to the Department for Science, Innovation and Technology to better understand what they are doing on digital platforms. I expect that many of the people who are going to respond to the consultation around the banning of social media for under-16s will come from the healthcare profession, because of the connections between mental health and eating disorders and the use of these platforms. Will he be proactively asking for action to make sure that young people are protected? That would also mean more resources for people who have eating disorders, because hopefully fewer people would be coming forward.

[Dr Ahmed]

My hon. Friend is absolutely right. Being proactive and following the evidence should be our north star when we are formulating policy; I know that is true of my right hon. Friend the Secretary of State for Science, Innovation and Technology.

The Royal College of Psychiatrists has been explicit about eating disorders and end-of-life care. Anorexia nervosa is not a terminal illness in its own right. The college’s guidance on medical emergencies in eating disorders was developed precisely to ensure that preventable deaths become a thing of the past. NHS England is clear that no patient with an eating disorder should routinely be placed in palliative care. Our focus must always be on treatment and recovery, and underpinned by the hope of recovery.

We also share concerns about the accurate recordings of deaths where eating disorders may have been a contributing factor. The hon. Member for Bath outlined some of her frustrations regarding correspondence with the Ministry of Justice and I would be happy to take up that call on her behalf to make sure that she gets the correspondence that she is entitled to. The statutory medical examiner and coroner system provides a clear framework to ensure that deaths are properly investigated and recorded so that lessons are identified and patient safety is strengthened.

Although it is for the coroner to exercise independent judicial discretion to determine what is recorded as the medical cause of death, I can reassure hon. Members that the coroner’s office has been undergoing training to ensure that the recording of deaths associated with eating disorders is done more accurately and proactively. Accurate recording matters, and we will continue to work with our partners, including colleagues in the Ministry of Justice and clinicians, to ensure that not only are the statistics captured, but the learning underpinning those statistics is reflected in genuine improvements to care.

Eating disorders are serious and complex mental illnesses that can affect anyone at any age and in any community or family. They require timely treatment, skilled professionals and sustained support thereafter.

Brain Tumour Survival Rates

Debate between Zubir Ahmed and Scott Arthur

Monday 9th February 2026 Commons Chamber

[Dr Ahmed]

I am hearing my hon. Friend’s call to action loud and clear. I can report to her that—this is in addition to the other ongoing clinical trials in the area of brain tumour and glioma research—in October 2025, RECURRENT-GB opened for recruitment. This is a new UK multi-centre randomised controlled trial, supported by nearly £2 million of NIHR funding, which will explore, for instance, whether surgery can improve the quality of life for patients with glioblastoma when the glioblastoma comes back after treatment. I know that my hon. Friend will hold our feet to the fire when it comes to recruitment and the money being used appropriately, and I am delighted to continue working with her in that regard.

Since this Government took office, over 213,000 more people are getting a cancer diagnosis on time, over 36,000 more people are starting treatment on time, and rates of early diagnosis are hitting record highs. Despite these vital signs of recovery, we know that our NHS is still failing far too many cancer patients and their families, as Members from across the House have highlighted this evening. We know that brain tumours remain one of the hardest cancers to treat, and it remains a challenging and underserved area of research.

Last week, the Government published our national cancer plan. We now have a blueprint to shift the dial on rare and challenging cancers, underpinned by three key targets. First, we aim to save 330,000 more lives by 2035 by ensuring that three in every four people diagnosed in 2035 will be cancer-free or living well with cancer five years after diagnosis. Secondly, we will achieve the three cancer performance targets, which I mentioned earlier, by the end of March 2029. Finally, we will improve the quality of life for people living with cancer.

Rare and less common cancers are a priority for the Government, and this is the first ever cancer plan with a whole chapter dedicated to rare cancers. We aim to be in the top quartile of European countries for 14 rare cancers, including brain tumours, where we currently rank 22nd out of 24. We will pull every lever available to drive improvements for these cancer types. We know that one of the most effective ways to improve survival from cancer, including brain cancer, is to catch it and treat it early, so we have committed to reducing the number of rare cancers diagnosed in emergency settings, including brain tumours, which cannot be staged like other cancers and have therefore not been previously captured by early diagnosis measures.

[Dr Arthur]

This is about equality. There is a fantastic charity called The Eve Appeal, which is focused on gynaecological cancers. It makes the point that a disproportionate number of people with these cancers end up being diagnosed in A&E, by which time it is too late. Through a meeting I had with Blood Cancer UK, I know that ethnic minorities are much more likely to face a diagnosis in A&E than in a doctor’s surgery. This is something that we should do, not just because it is the right thing to do but because it is a matter of equality.

[Dr Ahmed]

I could not agree more with my hon. Friend, and that is why NIHR funding has been specifically allocated. One of the tests for a grant is the diversity of the population it will serve.

We recognise the challenges presented by brain tumours. By publishing regular performance data at a more granular level and adding diagnosis in emergency settings to our basket of early diagnosis metrics, we are committed to moving the dial on these issues. For all patients diagnosed with rare cancers, we will prioritise access to specialist treatment and multidisciplinary teams to ensure that they benefit from the best of evidence-based care. We will work with charities to support rare cancer patients, and to ensure that they have access to the right information to manage their cancer care. We wish to be held accountable on these commitments and to drive forward progress for rare cancer patients, and we will therefore appoint a national clinical lead for rare cancers, who will provide independent arbitration.

The actions I have listed make up just a small part of our plan. It will turn cancer, which is one of the country’s biggest killers, into a treatable chronic condition. We have developed our plans with patients, charities, families and clinicians, and have heard from many Members today. We are grateful for the continued campaigning on rare cancers and brain tumours.